NextDecade Corp
For the period ended Dec 31, 2023. Filed Mar 11, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 11, 2024
NEXT$6.35+0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
(in thousands)
| Year Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Operating activities: | ||
| Net loss attributable to NextDecade Corporation | $(221,640) | $(60,071) |
| Adjustment to reconcile net loss to net cash used in operating activities | ||
| Depreciation | 168 | 162 |
| Share-based compensation expense | 26,553 | 7,472 |
| Loss on common stock warrant liabilities | 1,879 | 5,747 |
| Derivative loss, net | 44,803 | — |
| Net cash provided by settlement of derivative instruments | 4,138 | — |
| Amortization of right-of-use assets | 2,980 | 756 |
| Gain on sale of assets | (5,712) | — |
| Amortization of debt issuance costs | 41,390 | — |
| Loss on debt extinguishment | 9,531 | — |
| Interest expense | 26,432 | — |
| Amortization of other non-current assets | — | 354 |
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets | (940) | (314) |
| Accounts payable | 4,057 | 684 |
| Operating lease liabilities | (179) | (678) |
| Accrued expenses and other liabilities | (7,080) | 5,812 |
| Net cash used in operating activities | (73,620) | (40,076) |
| Investing activities: | ||
| Acquisition of property, plant and equipment | (1,737,636) | (33,753) |
| Acquisition of other non-current assets | (15,164) | (7,135) |
| Net cash used in investing activities | (1,752,800) | (40,888) |
| Financing activities: | ||
| Proceeds from debt issuance | 2,083,000 | — |
| Proceeds from sale of equity in subsidiaries | 457,659 | — |
| Proceeds from sale of preferred stock | — | 10,500 |
| Proceeds from sale of common stock | 254,400 | 115,000 |
| Repayment of debt | (233,000) | — |
| Debt and equity issuance costs | (494,270) | (3,952) |
| Preferred stock dividends | (53) | (75) |
| Shares repurchased related to share-based compensation | (9,627) | (3,272) |
| Net cash provided by financing activities | 2,058,109 | 118,201 |
| Net increase in cash, cash equivalents and restricted cash | 231,689 | 37,237 |
| Cash, cash equivalents and restricted cash – beginning of period | 62,789 | 25,552 |
| Cash, cash equivalents and restricted cash – end of period | $294,478 | $62,789 |
| Balance per Consolidated Balance Sheet: | ||
| December 31, 2023 | ||
| Cash and cash equivalents | $38,241 | |
| Restricted cash | 256,237 | |
| Total cash, cash equivalents and restricted cash | $294,478 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.